MyAverix Finance
SHG · Healthcare
Tibet Weixinkang Medicine Co Ltd (603676)
Drug Manufacturers - Specialty & Generic
Tibet Weixinkang Medicine Co Ltd (603676) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $4.59B, P/E ratio is 20.27, net margin is 19.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603676
Tibet Weixinkang Medicine Co Ltd (603676) — FAQ
What is Tibet Weixinkang Medicine Co Ltd's market cap?
Tibet Weixinkang Medicine Co Ltd (603676) has a reported market cap of $4.59B (data as of 2026-03-29).
What is 603676's P/E ratio?
The price-to-earnings (P/E) ratio for Tibet Weixinkang Medicine Co Ltd (603676) is 20.27 (data as of 2026-03-29).
Does Tibet Weixinkang Medicine Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Tibet Weixinkang Medicine Co Ltd (603676). Check the MyAverix Finance app for the latest dividend data.
What sector is Tibet Weixinkang Medicine Co Ltd in?
Tibet Weixinkang Medicine Co Ltd (603676) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603676 listed on?
603676 is listed on SHG.
What is Tibet Weixinkang Medicine Co Ltd's net margin?
Tibet Weixinkang Medicine Co Ltd (603676) reports a net margin of 19.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.